Related Experiment Video
Updated: Aug 15, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Liver disease in autosomal recessive polycystic kidney disease
Benjamin L Shneider1, Margret S Magid
1Recanati/Miller Transplantation Institute, New York, USA. Benjamin.Shneider@mssm.edu
Insights
Autosomal recessive polycystic kidney disease (ARPKD) often causes liver complications. Early screening and management of hepatic issues, including portal hypertension and biliary disease, are crucial for affected children.
Area of Science:
- Pediatric Nephrology
- Hepatology
- Medical Genetics
Background:
- Autosomal recessive polycystic kidney disease (ARPKD) is a genetic disorder frequently associated with significant hepatic complications.
- The PKHD1 gene, responsible for ARPKD, encodes fibrocystin, a protein crucial for bile duct development and function.
- Defects in fibrocystin lead to ductal plate malformations, resulting in major liver problems like portal hypertension and biliary disease.
Purpose of the Study:
- To outline the spectrum of hepatic complications in children diagnosed with autosomal recessive polycystic kidney disease (ARPKD).
- To detail recommended screening procedures for detecting liver disease in ARPKD patients.
- To discuss potential medical and surgical management strategies for hepatic manifestations of ARPKD.
Main Methods:
- Review of clinical presentations and diagnostic approaches for hepatic involvement in ARPKD.
- Screening protocols include complete blood count, physical examination, ultrasonography, and magnetic resonance (MR) cholangiography.
- Consideration of interventions for portal hypertension, biliary disease, and cholangitis.
Main Results:
- Hepatic complications are prevalent in children with ARPKD, primarily manifesting as portal hypertension and biliary disease.
- Standard screening methods effectively identify hepatic abnormalities.
- Prompt medical and surgical interventions can manage significant liver issues.
Conclusions:
- Early and thorough screening for hepatic disease is essential in all children with ARPKD.
- A high index of suspicion for cholangitis is necessary in ARPKD patients with biliary complications.
- Hepatic disease status must be integrated into treatment decisions, including renal transplantation considerations for ARPKD.
Abstract:
Hepatic complications occur in a significant proportion of children with autosomal recessive polycystic kidney disease (ARPKD). PKHD1/fibrocystin, the defective gene in ARPKD, is expressed in the cilia of bile duct epithelium and leads to abnormalities in the rubric of the ductal plate malformation. Portal hypertension and biliary disease are the major liver problems seen in ARPKD. Complete blood counting, physical examination, ultrasonography and magnetic resonance (MR) cholangiography are indicated as screening procedures for hepatic disease in ARPKD. Medical and surgical interventions are potentially indicated for children with portal hypertension and/or biliary disease. A high index of suspicion for the diagnosis of cholangitis needs to be maintained in children with biliary disease. The implications of hepatic disease need to be considered in the decision-making regarding renal transplantation in ARPKD.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Nephrons
Lysosomal Hydrolases
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pedigree Analysis

